Astria Therapeutics Inc (ATXS) support and resistance · rev $706.0K
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
This page maps Astria Therapeutics Inc (ATXS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
ATXS currently screens at market cap $382.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ATXS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ATXS quote page for the session range and the stock page for the full model.
Not investment advice.